IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Syngene International Limited is an Pharmaceutical based company, located in Bangalore, Syngene International Limited IPO size was 550.00 Cr. and was issued at 250.00 per share. The share of Syngene International Limited were listed at 310.40 per share and are currently trading at 727.00 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Manufactures critical high-voltage equipment for High Voltage Direct Current (HVDC) and Flexible AC Transmission Systems (FACTS) networks, enabling energy transition from renewable sources to power gr
Sangli
business of global digital and technology services with artificial intelligence.
Mumbai
Syngene International operates in Pharmaceutical and Development And Manufacturing At Its Ultra Modern World Class Research And Development Facility. The Issue is listed on BSE,NSE in Aug, 2015. Syngene International IPO size was 550.00 Cr. with Issue price of 250.00 .
Merchant Banker(s) of Syngene International IPO: Axis Bank Limited , Credit Suisse Securities (India) Private Limited , Jefferies India Private Limited
Syngene International IPO subscription was 32.05 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Syngene International IPO listed at a listing price of 310.40 against the offer price of 250.00.
The current market price of Syngene International is 727.00.
Why Us?
